[go: up one dir, main page]

NO20071107L - 1,1,2,2-tetra(hetero)aryletaner eller 1,1,2-tri(hetero)aryl-2-heterosyklyletaner som kaliumkanalinhibitorer - Google Patents

1,1,2,2-tetra(hetero)aryletaner eller 1,1,2-tri(hetero)aryl-2-heterosyklyletaner som kaliumkanalinhibitorer

Info

Publication number
NO20071107L
NO20071107L NO20071107A NO20071107A NO20071107L NO 20071107 L NO20071107 L NO 20071107L NO 20071107 A NO20071107 A NO 20071107A NO 20071107 A NO20071107 A NO 20071107A NO 20071107 L NO20071107 L NO 20071107L
Authority
NO
Norway
Prior art keywords
hetero
heterocyclylethanes
arylethanes
tetra
tri
Prior art date
Application number
NO20071107A
Other languages
English (en)
Inventor
Mark T Bilodeau
Zhicai Wu
John Hartnett
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20071107L publication Critical patent/NO20071107L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse angår forbindelser som har strukturen av formel (I) som er anvendbare som kaliumkanalinhibitorer for behandling av hjertearytmier.
NO20071107A 2004-07-29 2007-02-27 1,1,2,2-tetra(hetero)aryletaner eller 1,1,2-tri(hetero)aryl-2-heterosyklyletaner som kaliumkanalinhibitorer NO20071107L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29
PCT/US2005/026334 WO2006028590A1 (en) 2004-07-29 2005-07-25 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors

Publications (1)

Publication Number Publication Date
NO20071107L true NO20071107L (no) 2007-04-19

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071107A NO20071107L (no) 2004-07-29 2007-02-27 1,1,2,2-tetra(hetero)aryletaner eller 1,1,2-tri(hetero)aryl-2-heterosyklyletaner som kaliumkanalinhibitorer

Country Status (15)

Country Link
KR (1) KR20070043985A (no)
AR (1) AR049847A1 (no)
BR (1) BRPI0513793A (no)
CR (1) CR8876A (no)
EC (1) ECSP077208A (no)
IL (1) IL180846A0 (no)
MA (1) MA28980B1 (no)
MX (1) MX2007001188A (no)
NO (1) NO20071107L (no)
PE (1) PE20060382A1 (no)
RU (1) RU2344134C2 (no)
TW (1) TW200607493A (no)
UA (1) UA88018C2 (no)
WO (1) WO2006028590A1 (no)
ZA (1) ZA200700477B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012520829A (ja) * 2009-03-18 2012-09-10 メディキュア・インターナショナル・インコーポレーテッド チロフィバンの経皮用医薬製剤および投与
ES2675314T3 (es) 2012-06-11 2018-07-10 Bristol-Myers Squibb Company Profármacos de ácido fosforamídico de 5-[5-fenil-4-(piridin-2-ilmetilamino) quinazolin-2-il] piridin-3-sulfonamida

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2140865B2 (de) * 1971-08-14 1979-10-11 Bayer Ag, 5090 Leverkusen 1 -Imidazolyl-methanphosphonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE19951701A1 (de) * 1999-10-27 2001-05-03 Aventis Pharma Gmbh Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
EP1911740B1 (en) * 2002-01-04 2013-02-27 NeuroSearch A/S Potassium channel modulators

Also Published As

Publication number Publication date
AR049847A1 (es) 2006-09-06
ZA200700477B (en) 2009-08-26
TW200607493A (en) 2006-03-01
UA88018C2 (ru) 2009-09-10
CR8876A (es) 2007-08-28
PE20060382A1 (es) 2006-05-15
KR20070043985A (ko) 2007-04-26
BRPI0513793A (pt) 2008-05-13
RU2344134C2 (ru) 2009-01-20
WO2006028590A1 (en) 2006-03-16
ECSP077208A (es) 2007-02-28
RU2007107408A (ru) 2008-09-10
MX2007001188A (es) 2007-03-21
IL180846A0 (en) 2007-06-03
MA28980B1 (fr) 2007-11-01

Similar Documents

Publication Publication Date Title
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20081454L (no) Met-kinaseinhibitorer
NO20081196L (no) Terapeutisk middel for diabetes
WO2007085895A3 (en) Fap inhibitors
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
NO20064456L (no) Thiadiazolidinoner som GSK-3 inhibitorer
NO20081930L (no) Oksazolforbindelser og farmasoytiske blandinger
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
ATE433447T1 (de) Pyrimiidinverbindungen
NO20061251L (no) Fenyl eller pyridylamidforbindelser som prostaglanding-E2-antagonister
NO341663B1 (no) Cyklopropyl-kondenserte indolobenzaepin HCV NS5B inhibitorer
NO20082298L (no) Kaliumkanalinhibitorer
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
NO20082096L (no) Azaindol-2-karboksamidderivativer
ATE520651T1 (de) Substituierte phenylmethylbicyclocarbonsäureamidverbindungen
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
SA521422728B1 (ar) مثبطات فوسفوينوسيتيد 3- كيناز الموضعية
NO20070789L (no) Nikotinreseptoragonister for behandling av betennelsessykdommer
NO20065719L (no) I det vesentlige rene 2-{[2-(2-metylamino-pyrimidin-4-yl)-1H-indol-5-karbonyl]-amlno}-3-(fenylpyridin-2-yl-amino)-propionsyre som en IkB kinaseinhibitor.
EA200702062A1 (ru) Пиримидиндионовые производные как антагонисты прокинетициновых рецепторов
DE602004028493D1 (de) Isochinolinon-kaliumkanalinhibitoren
NO20080553L (no) Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander
WO2007017728A3 (en) Novel heterocyclic compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application